CRCL, a stablecoin company, has experienced a remarkable surge in its stock price since its initial public offering (IPO) two weeks ago. The stock debuted at $31 per share and has since climbed to nearly $259 in pre-market trading by June 23, 2025, representing an increase of approximately 744% to 844% from its IPO price. The rally included multiple daily gains ranging from 12% to over 30%, with the stock reaching all-time highs above $240 per share. Market capitalization has expanded rapidly, approaching $70 billion as of June 23. This surge reflects growing investor interest and heightened momentum in the crypto and stablecoin sectors. The stock's performance outpaced other related assets such as $COIN, which also saw gains but at a smaller scale. The rapid ascent of CRCL stock highlights intense market activity and enthusiasm surrounding the company and its sector.
$CRVO halted [CervoMed's Neflamapimod significantly slowed the progression of Dementia with Lewy Bodies (DLB) (54-64% risk reduction on CDR-SB) and reduced neurodegeneration (GFAP) in the RewinD-LB trial. Optimal drug levels and the absence of AD co-pathology enhanced the https://t.co/a6VgxGk0qQ
$CRVO halt
$CELC halt